Liquidia Corp - 8-K Filing
Liquidia Corp reports Q3 2026 net loss of $236.3M due to $389.7M litigation settlement with United Therapeutics, while YUTREPIA sales grew 31% QoQ. (Items: 2.02 Results of Operations and Financial Condition, 8.01 Other Events, 9.01 Financial Statements and Exhibits)